Global X Defense Tech ETF vs Summit Therapeutics Inc — how do they compare? Global X Defense Tech ETF trades at $60.14, while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). Which is the better fit depends on your goals.
| SHLD | SMMT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $78.02 | $29.32 |
52-Week Low | $58.20 | $13.05 |
Market Cap | — | $10.48B |
Enterprise Value | — | $9.90B |
Trailing returns across standard periods
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →